Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sagimet Biosciences (SGMT) Change in Cash (2023 - 2024)

Sagimet Biosciences (SGMT) has 2 years of Change in Cash data on record, last reported at -$80.8 million in Q2 2024.

  • For Q2 2024, Change in Cash fell 1409.85% year-over-year to -$80.8 million; the TTM value through Jun 2024 reached $4.3 million, changed N/A, while the annual FY2025 figure was -$40.8 million, 5922.97% down from the prior year.
  • Change in Cash reached -$80.8 million in Q2 2024 per SGMT's latest filing, down from $101.6 million in the prior quarter.
  • Across five years, Change in Cash topped out at $101.6 million in Q1 2024 and bottomed at -$99.8 million in Q4 2023.